Bharat Biotech

Bharat Biotech’s Covaxin Found To Be Safe, Induced Immune Response In Phase-1: Data

New Delhi: Bharat Biotech's coronavirus vaccine Covaxin has been found to be well-tolerated and produced an immune response, says the…

January 22, 2021

Centre Issues Letter Of Comfort To Bharat Biotech For 45 Lakh Doses Of Covaxin

New Delhi: Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of…

January 19, 2021

Bharat Biotech Advises People With Medical Conditions To Avoid Covaxin Jab

New Delhi: Covaxin manufacturer Bharat Biotech has warned people who are immuno-compromised or are on medicines that affect the immune…

January 19, 2021

Safety, Efficacy Of Covaxin: Plea In HC Seeks Information from DCGI

Mumbai: The debate over Bharat Biotech-manufactured Covaxin continues. A writ plea has been moved before the Bombay High Court seeking…

January 16, 2021

Covaxin Compensation Clause For Adverse Events Post Vaccination

New Delhi: Those receiving Bharat BioTech’s Covaxin during the nationwide vaccination drive against COVID-19 will have to sign a “consent…

January 16, 2021

COVID-19 Vaccine: ICMR Scientist Vouches For Safety Of Covaxin

New Delhi: Amid criticism of what many consider to be ‘premature’ emergency use approval given to Bharat Biotech’s Covaxin, a…

January 13, 2021

Vaccine Volunteer Died Of Suspected Poisoning, Claims Bharat Biotech

New Delhi: Following reports of a volunteer’s demise during its Phase 3 vaccine trials, Bharat Biotech on Saturday cited cardio…

January 9, 2021

Covaxin Likely To Be Cheaper Than Serum’s Covishield; Vaccines To Be Transported Soon

Bhubaneswar: Indigenously developed Covaxin COVID-19 vaccine by Bharat Biotech is likely to be priced lower than Serum Institute's Covishield. Covishield…

January 7, 2021

All Indian COVID-19 Vaccines Being Developed For Storage At 2-8 Degree Celsius, Says Govt Official

New Delhi: The logistics for storing all Indian vaccines being developed against the coronavirus at 2-8 degrees Celsius have been…

January 5, 2021

Bharat Biotech To Produce Data To Show Covaxin’s Efficacy On Mutant Strain

New Delhi: Bharat Biotech-developed vaccine candidate COVAXIN will be affective on mutant strains of the novel coronavirus, the company expressed…

January 5, 2021